Provided by Tiger Fintech (Singapore) Pte. Ltd.

CUTIA-B

9.720
0.000
Volume:- -
Turnover:- -
Market Cap:3.10B
PE:-6.30
High:9.720
Open:9.720
Low:9.720
Close:9.720
Loading ...

Company Profile

Company Name:
CUTIA-B
Exchange:
SEHK
Establishment Date:
2019
Employees:
333
Office Location:
Huanzhi Building,20th Floor,436 Heng Feng Road,Jingan District,Shanghai,China
Zip Code:
200070
Fax:
- -
Introduction:
Cutia Therapeutics is a China-based company mainly engaged in the research and development and manufacture of dermatological biological drugs. The Company is committed to developing comprehensive solutions to meet the diverse needs of patients and consumers in a wide range of dermatological treatment and care markets. The Company is mainly engaged in clinical trials of its core product CU-20401. This product is mainly used to treat submental fat accumulation. The Company conducts its businesses in the domestic market and overseas markets.

Directors

Name
Position
CHEN Lian Yong
Chairman of the Board,Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
ZHANG Le Le
Executive Director
HUANG Yu Qing
Executive Director
ZHONG Ming Jie
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
XIE Xiao Xiang
Independent Director,Chairman of the Remuneration and Assessment Committee,Audit Committee Member
TAO De Ren
Independent Director,Member of the Nomination Committee,Audit Committee Member
XIE Qin
Director
HUANG Xiao
Director
YANG Yun Xia
Director

Shareholders

Name
Position
ZHANG Le Le
CEO
HUANG Yu Qing
CFO
CHEN Shi Ting
Corporate Secretary
WU Jia Ru
Other Senior Executives
XU Jing Xin
Other Senior Executives
ZHANG Chun Na
Other Senior Executives
ZHU Qi
Other Senior Executives
LEI Lei
Other Senior Executives